Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
filingDate |
2012-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-103298345-B |
titleOfInvention |
combination |
abstract |
The present invention relates to a method of treating cancer in humans and pharmaceutical combinations useful in this treatment. In particular, the method relates to a method of cancer treatment comprising administering to a human in need thereof a proteasome inhibiting compound and N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl }-5-chloro-4-(4-chloro-1-methyl-1H-pyrazole-5-yl)-2-thiophene carboxamide or a pharmaceutically acceptable salt thereof, and optionally other antineoplastic drugs. |
priorityDate |
2011-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |